What Happened: On Tuesday, Moderna announced that it has initiated the application process for full approval of its Covid-19 vaccine from the US Food and Drug Administration. Moderna is seeking full approval for people ages 18 and up. Moderna also announced last week that it plans to seek emergency use approval of its vaccine for children ages 12-17, early this month. Photo Source: fda.gov #newspura #justfactsnoopinions #covid19 #coronavirus #news #breakingnews #breaking #vac
What Happened: On Monday, the Food and Drug Administration expanded emergency use authorization for Pfizer's Covid-19 vaccine to include children ages 12-15 years old. Pfizer had previously conducted a trial with 2,260 adolescent volunteers, the vaccine was shown to be 100% effective at preventing Covid-19 in children aged 12-15. The authorization sets the stage for a vaccine rollout for young teens before the start of the new school year. Photo Source: US DOD #newspura #just
What Happened: On Tuesday, the Center for Disease Control and Food and Drug Administration announced that they are recommending that the United States pause usage of the Johnson & Johnson Covid-19 vaccine, citing concerns over "rare and severe" blood clots. So far, there are six reported cases of these severe blood clots. Developing Story Photo Source: pixabay #newspura #justfactsnoopinions #covid19 #coronavirus #vaccine #johnsonandjohnson #oneshotvaccine #news #breaking #bre
What Happened: On Wednesday, AstraZeneca updated the data from their late-stage US trials saying that their Covid-19 vaccine is 76% effective at preventing symptomatic Covid-19 (down slightly from the 79% they originally reported on Monday) and 100% effective at preventing severe symptoms and hospitalizations. The company added that the vaccine is 85% effective in preventing symptoms in people 65 and older. On Tuesday, the Data and Safety Monitoring Board (DSMB) expressed con
What Happened: On Monday, AstraZeneca revealed that late-stage US trials showed their Covid-19 vaccine to be 79% effective at preventing symptomatic Covid-19 and 100% effective at preventing severe symptoms and hospitalizations. AstraZeneca added that the trials did not demonstrate any safety concerns including blood clots (a concern that was recently brought up by several countries). Although the AstraZeneca vaccine is already being used in more than 50 countries, it has not
What Happened: On Tuesday, President Biden announced that the United States will have enough COVID-19 vaccines for all adults by the end of May. This accelerates the original projected timeline by two months.
The new timeline does not guarantee that all adults will have received their shots by May 31, as distribution is still a factor. The accelerated timeline comes shortly after the FDA approved the Johnson & Johnson vaccine for emergency use. Biden also said he would direc
Latest Updates with the Coronavirus: The US reached another one day high of over 4,300 Covid-19 deaths. Global confirmed cases of Covid-19 have reached nearly 92 million and nearly 2 million deaths. Deaths and new cases have been rising sharply over the last 2.5 months. In the US, there are nearly a quarter million new cases per day. The US continues to be the hardest hit of all countries with nearly 23 million cases and 380,000+ deaths. (Source: Johns Hopkins). The Trump adm
What Happened: According to a report released by the Labor Department on Wednesday, 803,000 more Americans claimed first-time jobless benefits over the last week. In addition, nearly 400,000 more workers filed for assistance under the Pandemic Emergency Unemployment Compensation (PEUC) program. Continued jobless claims fell to 5.3 million, down around 200,000 from the previous week. However, economists warn that the numbers might be going down for the wrong reason. States wil
What Happened: On Sunday, a federal advisory panel recommended that people over 75 and essential workers like teachers, grocery store workers, police, firefighters, public transit workers, etc. be next in line for Covid-19 vaccine shots. An estimated 50 million people nationwide. The first people to receive vaccinations are healthcare workers and long term care facility members and staff, an estimated 24 million people nationwide. According to the CDC, over half a million Ame
What's Happening: According to Gen. Gustave Perna, chief operating officer of Operation Warp Speed, distribution of Moderna's Covid-19 vaccine has already begun in the US. The speedy rollout comes just one day after the FDA authorized Moderna's Covid-19 vaccine for emergency use. Said Perna, "Boxes are being packed and loaded today. Trucks will begin rolling out tomorrow, from FedEx and UPS, delivering vaccines and kits to the American people across the United States. This we
What Happened: On Thursday, the FDA's advisory panel endorsed Moderna's Covid-19 vaccine. Now the vote will go before FDA officials who will determine whether to grant emergency use authorization for the vaccine. The Moderna vaccine proved to be over 90% effective in late stage trials and is widely expected to receive emergency use approval over the next few days. If approved, Moderna's vaccine would be the second vaccine to receive emergency use authorization after Pfizer an
What Happened: According to a report released by the Labor Department on Thursday, 885,000 more Americans claimed first-time jobless benefits over the last week. This is the largest number of claims since mid-September and the second week in a row we have seen an increase in claims. Continued jobless claims fell to 5.5 million, down around 300,000 from the previous week. However, economists warn that the numbers might be going down for the wrong reason. States will typically
What Happened: On Tuesday, FDA scientists endorsed the safety and efficacy of Moderna's Covid-19 vaccine confirming it to be 94% effective at preventing severe cases of the virus. Next, the evidence will be discussed by a panel of independent experts on Thursday. If all goes well, the FDA could grant emergency use authorization for the Moderna Covid-19 vaccine as early as Friday. Developing Story Photo Source: fda.gov #newspura #justfactsnoopinions #covid19 #coronavirus #news
What Happened: On Friday, the US Food and Drug Administration formally approved Pfizer and BioNTech's Covid-19 vaccine for emergency use in the United States. This will allow widespread distribution of the vaccine which will go to health care workers and residents and staff of long-term care facilities first. The approval comes one day after the FDA advisory panel voted to allow emergency use of the Pfizer vaccine. With the approval, officials say vaccinations can start early
What Happened: On Thursday, the FDA's advisory committee recommended that the agency grant emergency use authorization of Pfizer and BioNTech's Covid-19 vaccine. Now the advisory committee for the Center for Disease Control must also vote on whether to use the Pfizer vaccine. The committee is expected to vote on Sunday. If the CDC committee supports the emergency use of the Pfizer vaccine as well, vaccines could start rolling out to citizens as soon as 24-48 hours afterwards.
What Happened: According to a report released by the Labor Department on Thursday, an additional 853,000 Americans claimed first-time jobless benefits over the last week. This is the largest number of claims since mid-September. This is also the third increase in the past four weeks, the only decline coming during the Thanksgiving holiday. Continued jobless claims rose to 5.8 million, up around 300,000 from the previous week. With only eight days to go before the next spendin
Latest Updates with the Coronavirus: Global confirmed cases of Covid-19 has reached nearly 68 million and over 1.5 million deaths. The US continues to be the hardest hit of all countries with over 15 million cases and 285,000+ deaths (Source: Johns Hopkins). Just in this last week the US set three new records: the highest number of daily deaths, the highest number of daily new infections and the highest number of daily hospitalizations. With several days in a row in which ove
What Happened: On Tuesday, an FDA advisory committee released a document confirming the efficacy and safety of Pfizer and BioNTech’s COVID-19 vaccine. The document confirmed that the vaccine’s efficacy was 95% seven days after the second dose. It also noted that the vaccine seems to provide “some protection” even after the first dose. The document also attests to the safety of the vaccine saying it was “favorable” and that the most common side effects were reactions at the in
What Happened: According to a report released by the Labor Department on Thursday, an additional 712,000 Americans claimed first-time jobless benefits Thanksgiving week. This is down from the previous week which had 787,000 new claims. Economists caution that the decrease is likely because of the Thanksgiving holiday and that we should expect the number to increase again next week. Continued jobless claims lowered to 5.5 million, down by around 600,000 from the previous week.
What Happened: Pharmaceutical company Moderna says it plans to apply for emergency use authorization of its' Covid-19 vaccine with the FDA on Monday. Moderna's latest data set shows its' vaccine to be 94.1% effective at preventing Covid-19 and 100% effective at preventing very severe cases of the disease. Said Dr. Paul Offit of the FDA's vaccine advisory committee, "This is striking...these are amazing data." Moderna will become the second company to apply with the FDA for em